Ventrus Biosciences (VTUS) Files $100M Mixed Shelf
Tweet
Share
E-mailGet Alerts VTUS Hot Sheet
Join SI Premium – FREE
Ventrus Biosciences Inc. (Nasdaq: VTUS) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $100 million of Common Stock, Preferred Stock, Warrants, Debt Securities, Units, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rainier Acquisition prices $75M IPO on Nasdaq
- argenx completes $77-per-share acquisition of Forte Biosciences
- Moderna plans $2B convertible notes offering due 2032
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
